Image

A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth

A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth

Recruiting
15-30 years
All
Phase N/A

Powered by AI

Overview

Clinical and radiographic assessment of A-prf,A-prf combined with nanochitosan compared to chitosan for symptomatic irreversible pulpits in lower permanent first molar

Description

3 groups are allocated using : Aprf Aprf combined with nanochitosan Chitosan

Each group will be subjected to tests:

Tooth sensibility via EPT (electrical pulp tester)and thermal test Radiolucency in digital radiograph Pain in NRS(6-12-24-72h)for 1 week

Eligibility

Inclusion Criteria:

  • Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
    • Patients of either gender aged from 15-30.
    • Tooth should give positive response to cold test.
    • Haemostasias should be achieved after total pulpotomy.
    • The tooth is restorable and free from advanced periodontal disease, cracks and splits.
    • Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
    • Patients who will agree to the consent and will commit to follow-up period.
    • Patients with mature root.
    • Patients with no internal or external resorption and no periapical lesions.
    • Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion Criteria:

  • Patients with immature roots.
    • Haemostasias after 10 minutes can not be controlled after total pulpotomy
    • Patients with any systemic disease that may affect normal healing.
    • Patients with periapical lesions or infections.
    • Pregnant females.
    • Patients who could/would not participate in a 6 months follow-up.
    • Patients with fistula or swelling
    • Patients with necrotic pulp.
    • Patients with old age.

Study details
    Pulpitis - Irreversible

NCT06438523

Future University in Egypt

11 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.